This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
HealthdirectFree Australian health advice you can count on. — Description, Dosage, Side Effects | PillsCard
OTC
HealthdirectFree Australian health advice you can count on.
15 mg/mL, Solution
INN: NIZATIDINE
Available in:
🇬🇧🇵🇹
Form
SOLUTION
Dosage
15 mg/mL
Route
ORAL
Storage
—
About This Product
Manufacturer
Amneal Pharmaceuticals LLC
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
ATC Code
A02BA04
Source
OPENFDA_NDC
(
ARTG
)
NIZATIDINE is indicated for up to 8 weeks for the treatment of active duodenal ulcer. In most patients, the ulcer will heal within 4 weeks. NIZATIDINE is also indicated for maintenance therapy of duodenal ulcer patients, at a reduced dosage of 150 mg h.s. after healing of an active duodenal ulcer. Continuous therapy with nizatidine for longer than 1 year has not been studied. NIZATIDINE is indicated for up to 8 weeks for the treatment of benign gastric ulcer. NIZATIDINE is indicated for up to 12 weeks for the treatment of oesophagitis, including erosive and ulcerative oesophagitis and associated heartburn due to reflux.
⚠️ Warnings
• Before initiating nizatidine therapy for active benign gastric ulcer, it is recommended to access the possibility of cancerous tumors of gastric ulceration.
• False positive test result for the presence of urobilinogen (abnormalities in urobilinogen levels leads to hemolytic anemia or various liver-related diseases) may occur during the treatment with nizatidine.
• The use of nizatidine in pregnant and nursing mothers needs medical specialist approval.
• Nizatidine treatment for heartburn or acid indigestion should be limited to 2 weeks. If symptoms persist after this time period, treatment has to be discontinued and medical advice should be considered.
• Dosage adjustments are required in patients with severe kidney disease.
